3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Hodgkin Disease
29
Lymphoma
17
Lymphoma, Large B-Cell, Diffuse
6
Lymphoma, Follicular
4
Vulvar Neoplasms
3
Testicular Neoplasms
3
Neoplasms, Germ Cell and Embryonal
3
Lymphoma, Non-Hodgkin
3
Lymphoma, Large-Cell, Immunoblastic
3
Seminoma
2
Ovarian Neoplasms
2
Neoplasms
2
Dendritic Cell Sarcoma, Interdigitating
2
Breast Neoplasms
2
Warts
1
Ulcer
1
Testicular Germ Cell Tumor
1
Teratoma
1
Stomach Neoplasms
1
Skin Neoplasms
1
Recurrence
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Processes
1
Ovarian Germ Cell Cancer
1
Neoplastic Processes
1
Neoplasms, Second Primary
1
Neoplasm Metastasis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Interventions
Cholecalciferol
2
Sunitinib
1
Morphine
1
Methadone
1
Letrozole
1
Electrochemotherapy
1
Control Groups
1
Clomiphene
1
Bleomycin
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pathologic Processes
×
Bleomycin
×
Clear all
NCT03040180
2019-01-25
nECT
Zealand University Hospital
Phase 2
Unknown
40 enrolled